Atlas Trials

AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia

Clinical trial NCT01798901 · COMPLETED

Trial details

NCT number
NCT01798901
Sponsor
Alison Walker
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaUntreated Adult Acute Myeloid Leukemia
Start date
2013-09-17
Primary completion
2015-02-19
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.